Pharma

Weekend Roundup: A drug for celiac disease and a VC who thinks healthcare is like witchcraft

A bite-sized review of life science current events you need to know about this week.

A bite-sized review of life science current events you need to know about this week.

A company developing a celiac disease drug to replace gluten-free eating in certain patients announced it began Phase 1 clinical trials. The drug takes aim at interfering with the body’s immune response to gluten in celiac patients.

presented by

Silicon Valley investor Vinod Khosla ruffled some feathers last week when he compared modern healthcare to witchcraft. The Sun Microsystems co-founder said healthcare needs to be more data-driven. Oh, and 80 percent of doctors will be replaced by technology.

What’s a great way to tick off your customers? Make them pay more. That’s what Envoy Medical, maker of the first fully implantable hearing aid system, Esteem, is finding out as it makes some changes that patients aren’t too keen on. Apparently, patients will now be required to pay for any adjustments by an Envoy-trained medical professional following the implant and activation. The company’s CEO says that the shift is occurring because patient’s care is best managed through their implanting surgeon and an Esteemed-trained audiologist, not the company.

Rare is the tweeting healthcare executive, but we managed to track down 10 of them.

Proteus Digital Health’s sensor pill was smart, but this is even smarter. It would be years before we see it on the market, but the next generation of smart medicine just may lie in a tiny chip that’s implanted inside the body and programmed wirelessly to release doses of drugs at the right time.

presented by

We didn’t write these, but you should read them anyway.

Tweets we liked this week: